137
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder

, &
Pages 1271-1280 | Received 07 Mar 2020, Accepted 09 Oct 2020, Published online: 22 Oct 2020

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
  • Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948.
  • Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490–499.
  • Tannock R. Rethinking ADHD and LD in DSM-5: proposed changes in diagnostic criteria. J Learn Disabil. 2013;46(1):5–25.
  • Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165.
  • Lara C, Fayyad J, De Graaf R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009;65(1):46–54.
  • Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65.
  • Johansen EB, Killeen PR, Russell VA, et al. Origins of altered reinforcement effects in ADHD. Behav Brain Funct. 2009;5(1):7.
  • Tripp G, Wickens JR. Neurobiology of ADHD. Neuropharmacology. 2009;57(7–8):579–589.
  • Sonuga-Barke EJ. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003;27(7):593–604.
  • Sagvolden T, Aase H, Johansen EB, et al., A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 2005;28(3):397–419.
  • Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192–202.
  • DuPaul GJ, Weyandt LL, O’Dell SM, et al. College students with ADHD: current status and future directions. J Atten Disord. 2009;13(3):234–250.
  • Faraone SV, Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005;9(2):384–391.
  • Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204–211.
  • Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. Ann N Y Acad Sci. 2001;931(1):1–16.
  • Mannuzza S, Klein RG, Bessler A, et al. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1222–1227.
  • Elkins IJ, McGue M, Lacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry. 2007;64(10):1145–1152.
  • Eakin L, Minde K, Hechtman L, et al. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord. 2004;8(1):1–10.
  • Weafer J, Milich R, Fillmore MT. Behavioral components of impulsivity predict alcohol consumption in adults with ADHD and healthy controls. Drug Alcohol Depend. 2011;113(2–3):139–146.
  • Cheung CH, Rijdijk F, McLoughlin G, et al. Childhood predictors of adolescent and young adult outcome in ADHD. J Psychiatr Res. 2015;62:92–100.
  • van Lieshout M, Luman M, Twisk JW, et al. A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood. Eur Child Adolesc Psychiatry. 2016;25(9):1007–1017.
  • Meyer A, Eilertsen D-E, Sundet JM, et al. Cross-cultural similarities in ADHD-like behaviour amongst south african primary school children. S Af J Psychol. 2004;34(1):122–138.
  • Schoeman R, de Klerk M. Adult attention-deficit hyperactivity disorder: A database analysis of South African private health insurance. S Af J Psychiatry. 2017;23(1). DOI:https://doi.org/10.4102/sajpsychiatry.v23i0.1010
  • Molina BS, Hinshaw SP, Arnold LE, et al. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD)(MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013;52(3):250–263.
  • Vogel T, Dom G, van de Glind G, et al. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15‐month follow‐up? A longitudinal study involving young Swiss men. Addiction. 2016;111(10):1867–1878.
  • Lee SS, Humphreys KL, Flory K, et al. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328–341.
  • Wilens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry. 2011;24(4):280.
  • Capusan AJ, Bendtsen P, Marteinsdottir I, et al. Genetic and environmental contributions to the association between attention deficit hyperactivity disorder and alcohol dependence in adulthood: A large population‐based twin study. Am J Med Genet B Neuropsychiatr Genet. 2015;168(6):414–422.
  • Edwards AC, Kendler KS. Twin study of the relationship between adolescent attention-deficit/hyperactivity disorder and adult alcohol dependence. J Stud Alcohol Drugs. 2012;73(2):185–194.
  • De Alwis D, Lynskey MT, Reiersen AM, et al. Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addict Behav. 2014;39(8):1278–1285.
  • Pedersen SL, Walther CA, Harty SC, et al. The indirect effects of childhood attention deficit hyperactivity disorder on alcohol problems in adulthood through unique facets of impulsivity. Addiction. 2016;111(9):1582–1589.
  • van de Glind G, Konstenius M, Koeter MW, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend. 2014;134:158–166.
  • Roncero C, Ortega L, Pérez-Pazos J, et al. Psychiatric comorbidity in treatment-seeking alcohol dependence patients with and without ADHD. J Atten Disord. 2015;23(12):1497–1504.
  • McAweeney M, Rogers NL, Huddleston C, et al. Symptom prevalence of ADHD in a community residential substance abuse treatment program. J Atten Disord. 2010;13(6):601–608.
  • Ohlmeier MD, Peters K, Wildt BTT, et al. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol. 2008;43(3):300–304.
  • Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723.
  • van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1–2):11–19.
  • Arias AJ, Gelernter J, Chan G, et al. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008;33(9):1199–1207.
  • Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry. 1993;34(2):75–82.
  • Estévez N, Dey M, Eich-Höchli D, et al. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men. Epidemiol Psychiatr Sci. 2016;25(3):255–266.
  • Herman AA, Stein DJ, Seedat S, et al. The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. South Afr Med J. 2009;99(5):339-344.
  • Dada S, Pluddemann A, Parry C, et al. Alcohol and drug abuse trends. South African Community Epidemiology Network on Drug Use: SACENDU Research Brief. 2011; 14(January-June2011 (Phase 30)).
  • Saban A, Flisher AJ, Grimsrud A, et al. The association between substance use and common mental disorders in young adults: results from the South African Stress and Health (SASH) Survey. Pan Afr Med J. 2014;17(Suppl 1):11.
  • Broos N, Schmaal L, Wiskerke J, et al. The relationship between impulsive choice and impulsive action: a cross-species translational study. PloS One. 2012;7(5):e36781.
  • Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304.
  • Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.
  • Von Diemen L, Bassani DG, Fuchs SC, et al. Impulsivity, age of first alcohol use and substance use disorders among male adolescents: a population based case–control study. Addiction. 2008;103(7):1198–1205.
  • Crunelle C, Matthys F. Cocaine dependence and attention deficit hyperactivity disorder. The neuroscience of cocaine. London: Elsevier; 2017. p. 383–393.
  • Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clin. 2004;27(2):283–301.
  • Wise RA. Roles for nigrostriatal - not just mesocorticolimbic - dopamine in reward and addiction. Trends Neurosci. 2009;32(10):517–524.
  • Franzen JD, Heinrichs-Graham E, White ML, et al. Atypical coupling between posterior regions of the default mode network in attention-deficit/hyperactivity disorder: a pharmaco-magnetoencephalography study. J Psychiatry Neurosci. 2013;38(5):333–340.
  • Vaughn MG, Beaver KM, DeLisi M, et al. Gene-environment interplay and the importance of self-control in predicting polydrug use and substance-related problems. Addict Behav. 2009;34(1):112–116.
  • Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–244.
  • Khantzian EJ. The self-medication hypothesis revisited: the dually diagnosed patient. Primary Psychiatry. 2003;10(9):47–54.
  • Khantzian EJ. Addiction as a self‐regulation disorder and the role of self‐medication. Addiction. 2013;108(4):668–669.
  • Mariani JJ, Khantzian EJ, Levin FR. The self‐medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict. 2014;23(2):189–193.
  • Young JT, Carruthers S, Kaye S, et al. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment‐seeking adults. Drug Alcohol Rev. 2015;34(6):683–693.
  • Kooistra L, Crawford S, Gibbard B, et al. Differentiating attention deficits in children with fetal alcohol spectrum disorder or attention‐deficit–hyperactivity disorder. Dev Med Child Neurol. 2010;52(2):205–211.
  • Fatséas M, Hurmic H, Serre F, et al. Addiction severity pattern associated with adult and childhood attention deficit hyperactivity disorder (ADHD) in patients with addictions. Psychiatry Res. 2016;246:656–662.
  • Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402–409.
  • Kessler RC, Adler LA, Gruber MJ, et al. Validity of the World Health Organization Adult ADHD Self‐Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52–65.
  • Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000. DOI:https://doi.org/10.4088/JCP.v61n0402
  • Charach A, Yeung E, Climans T, et al. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry. 2011;50(1):9–21.
  • Kumar SV, Chate SS, Patil NM, et al. Prevalence of undiagnosed and untreated attention deficit hyperactivity disorder in men with alcohol dependence: a case-control study. Arch Psychiatry Psychotherapy. 2018;1:26–32.
  • Dunne EM, Hearn LE, Rose JJ, et al. ADHD as a risk factor for early onset and heightened adult problem severity of illicit substance use: an accelerated gateway model. Addict Behav. 2014;39(12):1755–1758.
  • Kerridge B, Chou S, Pickering R. Substance use and psychiatric disorders among mexican americans and non-hispanic whites by immigration status. Prim Care Companion CNS Disord. 2019;21(1). DOI:https://doi.org/10.4088/PCC.18m02359
  • Chung W, Jiang S-F, Paksarian D, et al. Trends in the prevalence and incidence of attention-deficit/hyperactivity disorder among adults and children of different racial and ethnic groups. JAMA Network Open. 2019;2(11):e1914344–e.
  • Benjamin J, Li L, Patterson C, et al. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 1996;12(1):81.
  • Ebstein RP, Belmaker RH. Saga of an adventure gene: novelty Seeking, substance abuse and the dopamine D4 receptor (D4DR) exon III repeat polymorphism. Mol Psychiatry. 1997;2(5):381–384.
  • Swanson J, Flodman P, Kennedy J, et al. Dopamine genes and ADHD. Neurosci Biobehav Rev. 2000;24(1):21–25.
  • Faraone SV, Doyle AE, Mick E, et al. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1052–1057.
  • Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatric Clin. 2010;33(1):159–180.
  • Kiaris H. Genes, polymorphisms, and the making of societies: how genetic behavioral traits influence human cultures. Florida: Universal-Publishers; 2012.
  • Chen C, Burton M, Greenberger E, et al. Population migration and the variation of dopamine D4 receptor (DRD4) allele frequencies around the globe. Evol Human Behav. 1999;20(5):309–324.
  • Guelke L Freehold farmers and frontier settlers, 1657-1780. The shaping of South African society. 1989:1652–1840.
  • Giliomee HB, Mbenga B New History of South Africa: Nb Pub Limited; 2007.
  • Huntley Z, Maltezos S, Williams C, et al. Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatry. 2012;12(1):223.
  • Moura HF, Faller S, Benzano D, et al. The effects of ADHD in adult substance abusers. J Addict Dis. 2013;32(3):252–262.
  • Levy S, Katusic SK, Colligan RC, et al. Childhood ADHD and risk for substance dependence in adulthood: a longitudinal, population-based study. PloS One. 2014;9(8):e105640.
  • Crunelle CL, van den Brink W, Veltman DJ, et al. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. Eur Neuropsychopharmacol. 2013;23(12):1714–1723.
  • Ortal S, Johan F, Itai B, et al. The role of different aspects of impulsivity as independent risk factors for substance use disorders in patients with ADHD: a review. Curr Drug Abuse Rev. 2015;8(2):119–133.
  • Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, et al. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry. 2012;53(3):304–312.
  • Dada S, Burnhams B, Erasmus J, et al. Monitoring alcohol, tobacco and other drug abuse treatment admissions in South Africa South African Community Epidemiology Network on Drug Use (SACENDU). 2018(October 2018 (Phase 43)).
  • Fabricius V, Langa M, Wilson K. An exploratory investigation of co‐occurring substance‐related and psychiatric disorders. J Subst Use. 2008;13(2):99–114.
  • Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(1):i26–i31.
  • Ustun B, Adler LA, Rudin C, et al. The World Health Organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiatry. 2017;74(5):520–526.
  • Silverstein MJ, Faraone SV, Alperin S, et al. How informative are self-reported adult attention-deficit/hyperactivity disorder symptoms? An examination of the agreement between the adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1. 1 and adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale. J Child Adolesc Psychopharmacol. 2018;28(5):339–349.
  • Silverstein MJ, Faraone SV, Alperin S, et al. Validation of the expanded versions of the adult ADHD self-report scale v1. 1 symptom checklist and the adult ADHD investigator symptom rating scale. J Atten Disord. 2019;23(10):1101–1110.
  • Crunelle CL, van den Brink W, Moggi F, et al. International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Eur Addict Res. 2018;24(1):43–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.